UCR Startup Receives $2.25 Million to Test New Cancer Drug
Riverside company's treatment targets aggressive tumors including pancreatic cancer.
Two Riversiders visit Sendai, Japan, Riverside's first sister city relationship established in 1957.
Let us email you Riverside's news and events every morning. For free!